Cerus formed group to research optimal production of COVID-19 convalescent plasma
On Mar. 26, 2020, Cerus announced it had formed a collaborative research group with the aim of optimizing…
-
-
Xencor and Vir Biotech announced license agreement for use of Xtend XmAb antibody technology to treat COVID-19
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
-
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, announced government grant to fund bispecific antibody development platform
On Mar. 24, 2020, aTyr Pharma announced announced that the companyﾒs Hong Kong subsidiary, Pangu BioPharma, together with…
-
Cumberland Pharma Announced Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
On Mar. 23, 2020, Cumberland Pharmaceuticals announced a national initiative to support the treatment of patients with hospital-acquired and…
-
Sorrento and SmartPharm Therapeutics announced research and development collaboration develop a next-generation, gene-encoded antibody vaccine for COVID-19
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
-
CSL Group to help battle Coronavirus
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
-
Regeneron announced important advances in novel COVID-19 antibody program
On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…
-
Vir Biotec announced intent to collaborate with Biogen on manufacturing of antibodies to potentially treat COVID-19
On Mar. 12, 2020, Vir Biotech announced it had signed a letter of intent with Biogen for the…
-
Vir Biotec announced research collaboration with NIH Vaccine Research Center on antibodies against coronaviruses
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
-
Emergent BioSolutions initiated development of product candidates for treatment of Coronavirus
On Mar. 11, 2020, Emergent BioSolutions announced it has initiated development of two product candidates for treatment and…
-
Biotechnology | HIV | NIH | Therapeutics
Drug-delivery technology leads to sustained HIV antibody production in NIH study
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
-
Mount Sinai and Harbour BioMed collaborated to advance treatment of cancer and Coronavirus COVID-19
On Mar. 6, 2020, Mount Sinai Health System and Harbour BioMed (HBM) announced a multi-year, multifaceted collaboration to…
-
Vir Biotec and WuXi Biologics announced collaboration for global development of antibodies to treat COVID-19
On Feb. 25, 2020, Vir Biotech and WuXi Biologics announced a development and manufacturing collaboration to advance and…
-
Artificial intelligence yielded new antibiotic
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
-
Vir Biotec identified two antibodies that bind to spike protein of SARS-CoV-2
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
-
AbCellera mobilized response to the novel coronavirus outbreak as part of its DARPA P3 program
On Jan. 28, 2020, AbCellera confirmed that it had mobilized its pandemic response platform against the ongoing outbreak…
-
Vir Biotec applying multiple platforms to address public health risk from coronavirus
On Jan. 22, 2020, Vir Biotech announced it was working to rapidly determine whether its previously identified anti-coronavirus…
-
Lack of new antibiotics threatens global efforts to contain drug-resistant infections
On Jan. 17, 2020, the World Health Organization (WHO) reported that declining private investment and lack of innovation…
-
Researchers at Vanderbilt University Medical Center isolated an antibody that blocks bird flu
On Dec. 12, 2019, Vanderbilt University Medical Center (VUMC) researchers James Crowe Jr., MD, and colleagues announced they…
-
Chembio Diagnostics received WHO prequalification approval for HIV Self-Test
On Nov. 4, 2019, Chembio Diagnostics announced its SURE CHECK HIV Self-Test has received World Health Organization (WHO)…
-
IRBM signed agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies
On Sept. 9, 2019, IRBM announced the signing of a service and development agreement with The University of…
-
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Neurology
FDA authorized marketing of first diagnostic test for detecting Zika virus antibodies
On May 23, 2019, the U.S. Food and Drug Administration (FDA) authorized marketing of a diagnostic test to…
-
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
-
InBios received FDA clearance for its DENV detect NS1 ELISA test for early detection of Dengue fever
On Sept. 11, 2018, InBios announced that it received 510k marketing clearance from the U.S. Food and Drug…
-
AbCellera raises $10M for machine-learning fueled antibody discovery platform
On Sept. 27, 2018, AbCellera, a biotech startup based in Vancouver, B.C., announced that it has raised a…
-
InBios received FDA EUA for its ZIKV Detect IgM Capture ELISA diagnostic test for antibodies in human serum
On Aug. 19, 2016, InBios announced that it had received an Emergency Use Authorization (EUA) from the U.S….
-
InBios received USDA license for its West Nile Virus antibody detection kit for horses
On Jan. 24, 2014, InBios announced that it had licensed a U.S. Department of Agriculture (USDA) West Nile…
-
Sanford Health acquired Hematech
On Jan. 4, 2013, Sanford Health announced the acquisition of Sioux Falls-based biotech company Hematech, a subsidiary of…
-
Single antibody shrinks variety of human tumors transplanted into mice, study showed
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
-
Drs. Judith James and John Harley at the OMRF published an important study that showed certain antibodies for lupus were typically present years before the disease with diagnosed
On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…
